Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Ustekinumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Ustekinumabmarket, defines the market attractiveness level of Ustekinumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Ustekinumab industry, describes the types of Ustekinumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ustekinumab market and the development prospects and opportunities of Ustekinumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ustekinumab market in Chapter 13.
By Player:
Johnson & Johnson
Outlook Therapeutics
Formycon
EPIRUS BioPharma
Fuji Pharma
BioXpress
Mitsubishi Tanabe
Alvotech
NeuClone
Stada
Meiji
Harvest Moon Pharma
By Type:
Intravenous
Subcutaneous
By End-User:
Arthritis
Colitis
Lupus Erythematosus
Myositis Multiplex With Palmoplantar Pustulosis
Cirrhosis Of The Liver
Sarcoidosis
Diabetes
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Ustekinumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Ustekinumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Ustekinumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Ustekinumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Ustekinumab Market Analysis and Outlook to 2022
-
7.1 Global Ustekinumab Consumption (2017-2022)
-
7.2 United States Ustekinumab Consumption (2017-2022)
-
7.3 Europe Ustekinumab Consumption (2017-2022)
-
7.4 China Ustekinumab Consumption (2017-2022)
-
7.5 Japan Ustekinumab Consumption (2017-2022)
-
7.6 India Ustekinumab Consumption (2017-2022)
-
7.7 South Korea Ustekinumab Consumption (2017-2022)
8 Region and Country-wise Ustekinumab Market Analysis and Outlook to 2028
-
8.1 Global Ustekinumab Consumption Forecast (2022-2028)
-
8.2 United States Ustekinumab Consumption Forecast (2022-2028)
-
8.3 Europe Ustekinumab Consumption Forecast (2022-2028)
-
8.4 China Ustekinumab Consumption Forecast (2022-2028)
-
8.5 Japan Ustekinumab Consumption Forecast (2022-2028)
-
8.6 India Ustekinumab Consumption Forecast (2022-2028)
-
8.7 South Korea Ustekinumab Consumption Forecast (2022-2028)
9 Global Ustekinumab Market Outlook by Types and Applications to 2022
-
9.1 Global Ustekinumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
9.2 Global Ustekinumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Colitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Myositis Multiplex With Palmoplantar Pustulosis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cirrhosis Of The Liver Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Sarcoidosis Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Other Consumption and Growth Rate (2017-2022)
10 Global Ustekinumab Market Outlook by Types and Applications to 2028
-
10.1 Global Ustekinumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Ustekinumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Myositis Multiplex With Palmoplantar Pustulosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Cirrhosis Of The Liver Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Sarcoidosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Ustekinumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Ustekinumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Ustekinumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Ustekinumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Ustekinumab Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Ustekinumab Product and Service
-
14.2 Outlook Therapeutics
-
14.2.1 Outlook Therapeutics Company Details
-
14.2.2 Outlook Therapeutics Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Outlook Therapeutics Ustekinumab Product and Service
-
14.3 Formycon
-
14.3.1 Formycon Company Details
-
14.3.2 Formycon Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Formycon Ustekinumab Product and Service
-
14.4 EPIRUS BioPharma
-
14.4.1 EPIRUS BioPharma Company Details
-
14.4.2 EPIRUS BioPharma Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 EPIRUS BioPharma Ustekinumab Product and Service
-
14.5 Fuji Pharma
-
14.5.1 Fuji Pharma Company Details
-
14.5.2 Fuji Pharma Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Fuji Pharma Ustekinumab Product and Service
-
14.6 BioXpress
-
14.6.1 BioXpress Company Details
-
14.6.2 BioXpress Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 BioXpress Ustekinumab Product and Service
-
14.7 Mitsubishi Tanabe
-
14.7.1 Mitsubishi Tanabe Company Details
-
14.7.2 Mitsubishi Tanabe Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Mitsubishi Tanabe Ustekinumab Product and Service
-
14.8 Alvotech
-
14.8.1 Alvotech Company Details
-
14.8.2 Alvotech Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Alvotech Ustekinumab Product and Service
-
14.9 NeuClone
-
14.9.1 NeuClone Company Details
-
14.9.2 NeuClone Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 NeuClone Ustekinumab Product and Service
-
14.10 Stada
-
14.10.1 Stada Company Details
-
14.10.2 Stada Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Stada Ustekinumab Product and Service
-
14.11 Meiji
-
14.11.1 Meiji Company Details
-
14.11.2 Meiji Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Meiji Ustekinumab Product and Service
-
14.12 Harvest Moon Pharma
-
14.12.1 Harvest Moon Pharma Company Details
-
14.12.2 Harvest Moon Pharma Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Harvest Moon Pharma Ustekinumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Ustekinumab
-
Figure Ustekinumab Picture
-
Table Global Ustekinumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ustekinumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Ustekinumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Ustekinumab Consumption by Country (2017-2022)
-
Figure United States Ustekinumab Consumption and Growth Rate (2017-2022)
-
Table Europe Ustekinumab Consumption and Growth Rate (2017-2022)
-
Figure China Ustekinumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Ustekinumab Consumption and Growth Rate (2017-2022)
-
Figure India Ustekinumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Ustekinumab Consumption and Growth Rate (2017-2022)
-
Figure Global Ustekinumab Consumption Forecast by Country (2022-2028)
-
Figure United States Ustekinumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Ustekinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Ustekinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Ustekinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Ustekinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Ustekinumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
Figure Global Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Lupus Erythematosus Consumption and Growth Rate (2017-2022)
-
Figure Global Myositis Multiplex With Palmoplantar Pustulosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cirrhosis Of The Liver Consumption and Growth Rate (2017-2022)
-
Figure Global Sarcoidosis Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lupus Erythematosus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Myositis Multiplex With Palmoplantar Pustulosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cirrhosis Of The Liver Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sarcoidosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Ustekinumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Ustekinumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Ustekinumab Product and Service
-
Table Outlook Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Outlook Therapeutics Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Outlook Therapeutics Ustekinumab Product and Service
-
Table Formycon (Foundation Year, Company Profile and etc.)
-
Table Formycon Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Formycon Ustekinumab Product and Service
-
Table EPIRUS BioPharma (Foundation Year, Company Profile and etc.)
-
Table EPIRUS BioPharma Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table EPIRUS BioPharma Ustekinumab Product and Service
-
Table Fuji Pharma (Foundation Year, Company Profile and etc.)
-
Table Fuji Pharma Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fuji Pharma Ustekinumab Product and Service
-
Table BioXpress (Foundation Year, Company Profile and etc.)
-
Table BioXpress Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioXpress Ustekinumab Product and Service
-
Table Mitsubishi Tanabe (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Ustekinumab Product and Service
-
Table Alvotech (Foundation Year, Company Profile and etc.)
-
Table Alvotech Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alvotech Ustekinumab Product and Service
-
Table NeuClone (Foundation Year, Company Profile and etc.)
-
Table NeuClone Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table NeuClone Ustekinumab Product and Service
-
Table Stada (Foundation Year, Company Profile and etc.)
-
Table Stada Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Ustekinumab Product and Service
-
Table Meiji (Foundation Year, Company Profile and etc.)
-
Table Meiji Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meiji Ustekinumab Product and Service
-
Table Harvest Moon Pharma (Foundation Year, Company Profile and etc.)
-
Table Harvest Moon Pharma Ustekinumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Harvest Moon Pharma Ustekinumab Product and Service
-
